U.S. company strikes deal with Poland for isotope used in medical tests

Feb 17, 2010 By Thomas H. Maugh II

As U.S. physicians face an impending crisis caused by lack of a crucial isotope used in many diagnostic procedures, a U.S. company said Wednesday that it had reached an agreement with the Polish nuclear energy agency to obtain the isotope from a reactor in that country.

Covidien, a St. Louis company that processes a radioisotope produced by reactors into a form that can be used in the medical tests, said that Poland's Institute of Atomic Energy will provide enough molybdenum-99 from the agency's Maria Research to meet the needs of about 1 million patients annually.

That is not nearly enough of the isotope to replace the shortage resulting from the shutdown of the two primary reactors that produce the element, but experts said it is enough to allow radiologists to keep performing some tests rather than shutting down.

"This is only a short-term fix to a long-term problem," said Robert W. Atcher, who heads a task force of SNM, formerly the Society of Nuclear Medicine, looking at ways to alleviate the shortage.

Molybdenum-99 is a short-lived radioisotope that breaks down into technetium-99m (the m stands for metastable) -- the form that is used in medical tests. With a half-life of only six hours, the isotope allows physicians to examine blood flow and bones and identify tumors before quickly disappearing from the body, thereby minimizing radiation dose.

When supplies of technetium-99m are adequate, about 55,000 Americans every day and tens of thousands in the rest of the world undergo such tests. But the isotope is produced primarily in five reactors around the world, all of them over the age of 45 and none in the United States.

Canada's National Research Universal reactor in Chalk River has been shut down since last May because of tritium leaks and other problems and is not expected to reopen before April. A second major reactor, in Petten, the Netherlands, will close Friday for four to six months of scheduled maintenance. The two reactors account for about two-thirds of the technetium-99m used in the United States.

Because the radioisotope decays so fast, it cannot be stockpiled. As a consequence, technicians are scheduling tests at all hours of the day and night whenever they receive a supply. Many are also resorting to older, less efficient tests that have seen only limited use in the last 20 years.

Covidien said a test run was conducted last week at the Maria reactor -- named after Polish nuclear physicist Maria Skladowsky Curie -- and the product is now being processed into technetium-99m at one of Covidien's European facilities. The company said it should begin distributing technetium-99m to European customers within 30 days.

But some complications remain. Among other things, the U.S. Food and Drug Administration must also test the finished product before it can be used in this country.

Explore further: Medtronic spends $350M on another European deal

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

New method for manufacturing radio isotopes

Sep 11, 2008

Thanks to a newly-developed technology at the Delft University of Technology in the Netherlands, global shortages of radio isotopes for cancer diagnosis could be a thing of the past. This is the message from Prof. Bert Wolterbeek ...

Rebooting of Canadian medical isotope reactor delayed

Aug 13, 2009

A Canadian reactor that produced one-third of the world's supply of medical isotopes before it closed in May for repairs will remain offline at least until early 2010, nuclear authorities said Thursday.

Recommended for you

Cold cash just keeps washing in from ALS challenge

9 hours ago

In the couple of hours it took an official from the ALS Association to return a reporter's call for comment, the group's ubiquitous "ice bucket challenge" had brought in a few million more dollars.

Medtronic spends $350M on another European deal

Aug 27, 2014

U.S. medical device maker Medtronic is building stronger ties to Europe, a couple months after announcing a $42.9 billion acquisition that involves moving its main executive offices across the Atlantic, where it can get a ...

Mind over matter for people with disabilities

Aug 26, 2014

People with serious physical disabilities are unable to do the everyday things that most of us take for granted despite having the will – and the brainpower – to do so. This is changing thanks to European ...

Ukraine's former world's tallest man dies

Aug 25, 2014

Ukraine's tallest man, who briefly held the world record but gave it up to live as a recluse, has died due to complications from the condition that saw him never stop growing, local media reported Monday.

User comments : 0